Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Glenmark Pharmaceuticals s.r.o., against the decision of the State Institute for Drug Control from 19. 12. 2016, under the no. SUKLS242635/2016 - 

The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Pfizer Limited, against the decision of the State Institute for Drug Control from 25. 11. 2016, under the no. SUKLS235908/2016 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven, against the decision of the State Institute for Drug Control from 3. 11. 2015, under the no. SUKLS268350/2012 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).     

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelan Pfizer Limited, against the decision of the State Institute for Drug Control from 19. 9. 2016, under the no. SUKLS230249/2016 - The appeal is dismissed and the decision under appeal is upheld.

 

More information: MZCR.cz (czech version only)

 

This note describes the taxation of energy use in the Czech Republic. It contains the country’s energy tax profiles, followed by country-specific information to complement the general discussion in Taxing Energy Use 2018 (OECD, 2018).

 

Více na: OECD.org - Czech Republic

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).     

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Glaxo group Limited, against the decision of the State Institute for Drug Control from 25. 10. 2016, under the no. SUKLS217181/2016 - The appeal is dismissed and the decision under appeal is upheld.

 

More information: MZCR.cz (czech version only)